United States· US:58411-499_47a979e6-9974-9d6d-e063-6394a90ae0c8
SHISEIDO SYNCHRO SKIN SELF-REFRESHING FOUNDATION 340 OAK
A medicinal product containing octinoxate; titanium dioxide, registered in United States by SHISEIDO AMERICAS CORPORATION.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- OCTINOXATE; TITANIUM DIOXIDE
- Manufacturer
- SHISEIDO AMERICAS CORPORATION
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1158411499101 BOTTLE in 1 CARTON (58411-499-10) / 30 mL in 1 BOTTLE
- ndc1158411-499-10
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Octinoxate; titanium dioxide in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b7c0a63a-c13d-4310-a58b-351fcd7a0a6c GET /v1/drugs/b7c0a63a-c13d-4310-a58b-351fcd7a0a6c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "1.69; 2.001",
"substance": "OCTINOXATE; TITANIUM DIOXIDE",
"productndc": "58411-499",
"dosage_form": "EMULSION",
"dea_schedule": null,
"strength_unit": "g/30mL; g/30mL",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about octinoxate; titanium dioxide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.